tiprankstipranks
Advertisement
Advertisement

Ligand raises FY25 adjusted EPS view to $6.70-$7.00 from $6.00-$6.25

FY25 EPS consensus $6.12. Raises FY25 revenue view to $200M-$225M from $180M-$200M, consensus $194.02M

Claim 55% Off TipRanks

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1